Empyrean Capital Partners’s Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 VLD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-248,184
Closed -$526K 175
2022
Q1
$526K Hold
248,184
0.01% 152
2021
Q4
$412K Sell
248,184
-203,413
-45% -$439K 0.01% 155
2021
Q3
$695K Buy
+451,597
New +$695K 0.02% 153

Other funds holding VLD.WS

Empyrean Capital Partners's VLD.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (VLD.WS) in Q2 2022, closing a stake of 248,184 shares — an estimated $526K sold.

Empyrean Capital Partners first reported a position in VLD.WS in Q3 2021 and held it in 3 quarters. The position peaked at $695K in Q3 2021. 22 funds tracked by Wall St. Rank hold VLD.WS as of Q2 2022.

  • Empyrean Capital Partners reported no remaining Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 248,184 Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q2 2022, an estimated $526K.
  • Empyrean Capital Partners first reported a position in Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q3 2021 and held it in 3 quarters.
  • Empyrean Capital Partners's Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $695K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.